A MULTICENTER PLACEBO-CONTROLLED DOUBLE BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SANDOSTATIN ( SMS 201-995 ) IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY RELATED DIARRHEA WHO WERE EITHER "RESPONDERS" OR "NON-RESPONDERS" IN A PRIOR PLACEBO-CONTROLLED DOUBLE-BLIND SANDOSTATIN STUDY.: